Cutaneous adverse drug reaction referrals to a liaison dermatology service

Teo, Ying; Walsh, Sarah; Creamer, Daniel

doi:10.1111/bjd.15461

Cited by 7 publications

(14 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Letter to the Editor re: 'Long-term complications of Stevens-Johnson syndrome/ toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up' DOI: 10.1111/bjd.15734 DEAR EDITOR, We read with great interest, the review paper by Lee et al 1 on the long-term complications of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). We would like to congratulate the authors on this important and excellent overview.…”

Section: Conflicts Of Interest: None Declaredmentioning

confidence: 99%

“…1 The authors assessed the number and types of cADR encountered and subsequent documentation. 1 The diagnosis and management of cADR has been recognised by National Institute for Health and Care Excellence (NICE) Guidelines on Drug Allergy as a high-priority area for quality improvement. 2 We commend Teo and colleagues 1 for examining an essential, yet often overlooked, component of health service quality.…”

mentioning

confidence: 99%

“…Dear Editor , We read with interest Teo et al . 's recently published article examining cutaneous adverse drug reactions (cADR) referred to an inpatient liaison dermatology service . The authors assessed the number and types of cADR encountered and subsequent documentation .…”

mentioning

confidence: 99%

“…'s recently published article examining cutaneous adverse drug reactions (cADR) referred to an inpatient liaison dermatology service . The authors assessed the number and types of cADR encountered and subsequent documentation . The diagnosis and management of cADR has been recognised by National Institute for Health and Care Excellence (NICE) Guidelines on Drug Allergy as a high‐priority area for quality improvement .…”

mentioning

confidence: 99%

“…The diagnosis and management of cADR has been recognised by National Institute for Health and Care Excellence (NICE) Guidelines on Drug Allergy as a high‐priority area for quality improvement . We commend Teo and colleagues for examining an essential, yet often overlooked, component of health service quality. We would like to further highlight the importance of risk communication, documentation and patient‐centred care, aspects that are imperative for severe cADR.…”

mentioning

confidence: 99%

See 4 more Smart Citations

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

2017

View full text Add to dashboard Cite

DEAR EDITOR, We read with interest Teo et al.'s recently published article examining cutaneous adverse drug reactions (cADR) referred to an inpatient liaison dermatology service. 1 The authors assessed the number and types of cADR encountered and subsequent documentation. 1 The diagnosis and management of cADR has been recognised by National Institute for Health and Care Excellence (NICE) Guidelines on Drug Allergy as a high-priority area for quality improvement. 2 We commend Teo and colleagues 1 for examining an essential, yet often overlooked, component of health service quality. We would like to further highlight the importance of risk communication, documentation and patient-centred care, aspects that are imperative for severe cADR.To ensure prompt causality assessment, documentation and risk communication, we suggest a model of care with a resourced, centralized, multidisciplinary adverse drug reaction review committee (ADRRC) within each health service that is responsible for systematically reviewing cADR episodes, particularly those that are severe in nature, such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug rash with eosinophilia and systemic symptoms (DRESS). 3 Members of the ADRRC should ideally include dermatologists, internal medicine physicians, clinical pharmacologists, pharmacists, immunologists and infectious diseases specialists. The ADRRC should address follow-up arrangements and refer patients for further allergy testing as required.In Teo et al.'s study, only one in five (19%) inpatient discharge summaries included the cADR episode. 1 As discharge summaries are the principal document for conveying information to community doctors, 1,3 incomplete risk communication on discharge may lead to inadvertent re-exposure and subsequent development of more serious outcomes. We recommend that health systems explore innovative solutions to benchmark and improve risk communication, for example, specialist pharmacist involvement in timely assessment and reporting of cADR, within healthcare resource limitations.As well as implementing enhanced systematic platforms to improve communication across the hospital-community interface, we propose the addition of a consumer-centred approach, whereby patients are provided with both written and verbal information. 3 A drug allergy passport, alert card or certificate with a discharge letter after medical evaluation are recommended for patients with drug hypersensitivity. 4 Clear risk communication highlighting the nature of the reaction, causal medication(s) and structurally related medications for avoidance, while also providing therapeutic options, is essential to inform clinicians and provide patient-centred care.

show abstract

Section: Conflicts Of Interest: None Declaredmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

2017

View full text Add to dashboard Cite

show abstract

Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus

Aung

Walker

Khu

et al. 2022

Eur J Clin Pharmacol

View full text Add to dashboard Cite

Purpose Adverse drug reactions (ADRs) contribute significantly to healthcare burden. However, they are largely preventable through appropriate management processes. This narrative review aims to identify the quality indicators that should be considered for routine monitoring of processes within hospital ADR management systems. It also examines the potential reasons behind variation in ADR management practices amongst HCPs, and explores possible solutions, focusing on targeted education programmes, to improve both the quality and quantity indicators of ADR management processes. Methods A comprehensive literature review was conducted to explore relevant themes and topics concerning ADR management, quality indicators and educational interventions. Results Substantial variability exists in ADR management amongst healthcare professionals (HCPs) with regard to reporting rates, characteristics of ADRs reported, quality of assessment, completeness of reports and, most importantly, risk communication practices. These variable practices not only threaten patient safety but also undermine pharmacovigilance processes. To date, quality indicators to monitor ADR management practices within hospital settings remain ill-defined. Furthermore, evidence behind effective interventions, especially in the form of targeted education strategies, to improve the quality of ADR management remains limited. Conclusions The focus of ADR management in hospitals should be to promote patient safety through comprehensive assessment, risk communication and safe prescribing. There is a need to develop a system to define, measure and monitor the quality of ADR management. Educational strategies may help improve the quality of ADR management processes.

show abstract

Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases

Martins

Seque

Porro

2022

Anais Brasileiros de Dermatologia

View full text Add to dashboard Cite

Cutaneous adverse drug reaction referrals to a liaison dermatology service

Cited by 7 publications

References 6 publications

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

The importance of risk communication and documentation for patients with cutaneous adverse drug reactions

Adverse drug reaction management in hospital settings: review on practice variations, quality indicators and education focus

Clinical aspects and therapeutic approach of drug-induced adverse skin reactions in a quaternary hospital: a retrospective study with 219 cases

Contact Info

Product

Resources

About